Tag: Nasdaq:CMRX
Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir)...
DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat...